Design, synthesis and antiproliferative evaluation of lipidated 1,3-diaryl propenones and their cyclized pyrimidine derivatives as tubulin polymerization inhibitors

Abubaker Mustafa Abdelaal Elsayed

QR Code Link :
Type :	article
Subject :	Q Science (General)
ISSN :	2211-7156
Main Author :	Abubaker Mustafa Abdelaal Elsayed
Title :	Design, synthesis and antiproliferative evaluation of lipidated 1,3-diaryl propenones and their cyclized pyrimidine derivatives as tubulin polymerization inhibitors

Place of Production :	Tanjung Malim
Publisher :	Fakulti Sains dan Matematik
Year of Publication :	2023
Notes :	Results in Chemistry
Corporate Name :	Universiti Pendidikan Sultan Idris
HTTP Link :	Click to view web link

Abstract : Universiti Pendidikan Sultan Idris

Malignant transformations are dependent on an aberrant increase in tubulin and microtubule activities for cancer cell growth, migration, invasion and metastasis. The present work includes design and synthesis of a new series of lipidated 1,3-diaryl propenones and their cyclized pyrimidine derivatives as tubulin polymerization inhibitors. These derivatives harness lipophilicity, ease of synthesis and antiproliferative activity of lipidated 1,3-diaryl propenones and their cyclized derivatives. New compounds were synthesized from 4?-hydroxyacetophenone via O-alkylation, condensation with different aromatic aldehydes followed by cyclization with urea, thiourea or guanidine. Cyclization of 1,3-diaryl propenones into 4,6-diaryl pyrimidines increased their antiproliferative activity with the most potent derivative 19 achieving IC50 values at low micro molar concentration against two human cancer cell lines; MCF-7 (breast) and HepG-2 (liver). Compound 19 induced S-phase cell cycle arrest and apoptosis in MCF-7 with tubulin IC50 = 9.7 ?M. It is well accommodated at the colchicine binding site of the tubulin protein as demonstrated by molecular docking. 2023 The Authors

References

A. Ritter, N.-N. Kreis, Microtubule dynamics and cancer, MDPI 14 (18) (2022) 4368.

O. Wattanathamsan, V. Pongrakhananon, Emerging role of microtubule-associated proteins on cancer metastasis, Front. Pharmacol. 3859 (2022).

H.V. Goodson, E.M. Jonasson, Microtubules and microtubule-associated proteins, Cold Spring Harb. Perspect. Biol. 10 (6) (2018) a022608.

B.R. Oakley, An abundance of tubulins, Trends Cell Biol. 10 (12) (2000) 537–542.

Garcin, C.; Straube, A. Microtubules in cell migration. Essays in biochemistry 2019, 63 (5), 509-520.

G. Borisy, R. Heald, J. Howard, C. Janke, A. Musacchio, E. Nogales, Microtubules: 50 years on from the discovery of tubulin, Nat. Rev. Mol. Cell Biol. 17 (5) (2016) 322–328.

Y. Ilan, Microtubules: From understanding their dynamics to using them as potential therapeutic targets, J. Cell. Physiol. 234 (6) (2019) 7923–7937.

L. Lafanech`ere, The microtubule cytoskeleton: An old validated target for novel therapeutic drugs, Front. Pharmacol. 3888 (2022).

W. Krause, Resistance to anti-tubulin agents: From vinca alkaloids to epothilones, Cancer Drug Resist. 2 (1) (2019) 82.

L. Lei, X.-J. Wang, S.-C. Tang, Novel taxanes in development: hopes or hypes? Crit. Rev. Oncol. Hematol. 176 (2022) 103727.

K.E. Arnst, S. Banerjee, H. Chen, S. Deng, D.J. Hwang, W. Li, D.D. Miller, Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy, Med. Res. Rev. 39 (4) (2019) 1398–1426.

E.C. McLoughlin, N.M. O’Boyle, Colchicine-binding site inhibitors from chemistry to clinic: a review, Pharmaceuticals 13 (1) (2020) 8.

R.A. Terkeltaub, D.E. Furst, K. Bennett, K.A. Kook, R. Crockett, M.W. Davis, High versus low dosing of oral colchicine for early acute gout flare: twenty-four–hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study, Arthritis Rheum. 62 (4) (2010) 1060–1068.

W. Liu, Y. He, Z. Guo, M. Wang, X. Han, H. Jia, J. He, S. Miao, S. Wang, Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation, J. Enzyme Inhib. Med. Chem. 38 (1) (2023) 2155815.

W. Liu, H. Jia, M. Guan, M. Cui, Z. Lan, Y. He, Z. Guo, R.u. Jiang, G. Dong, S. Wang, Discovery of novel tubulin inhibitors targeting the colchicine binding site via virtual screening, structural optimization and antitumor evaluation, Bioorg. Chem. 118 (2022) 105486.

G.S¸ . Karatoprak, E. Küpeli Akkol, Y. Genç, H. Bardakcı, Ç. Yücel, E. SobarzoS´ anchez, Combretastatins: an overview of structure, probable mechanisms of action and potential applications, Molecules 25 (11) (2020) 2560.

L. Li, S. Jiang, X. Li, Y. Liu, J. Su, J. Chen, Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site, Eur. J. Med. Chem. 151 (2018) 482–494.

W. Liu, M. He, Y. Li, Z. Peng, G. Wang, A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors, J. Enzyme Inhib. Med. Chem. 37 (1) (2022) 9–38.

F.O. Ojike, N. Lavignac, M.A. Casely-Hayford, Synthesis and in vitro bioactivity of polyunsaturated fatty acid conjugates of combretastatin A-4, J. Nat. Prod. 81 (9) (2018) 2101–2105.

T. Wong, S. Narayanan, D.P. Brown, Z.-S. Chen, Synthesis and cytotoxicity studies of stilbene long-chain fatty acid conjugates, J. Nat. Prod. 83 (5) (2020) 1563–1570. [21] B. Kumar, P. Sharma, V.P. Gupta, M. Khullar, S. Singh, N. Dogra, V. Kumar, Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies, Bioorg. Chem. 78 (2018) 130–140.

V. Mavrikaki, A. Pagonis, I. Poncin, I. Mallick, S. Canaan, V. Magrioti, J.- F. Cavalier, Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives, Bioorg. Med. Chem. Lett. 64 (2022) 128692.

Z. Ngaini, S.M.H. Fadzillah, H. Hussain, Synthesis and antimicrobial studies of hydroxylated chalcone derivatives with variable chain length, Nat. Prod. Res. 26 (10) (2012) 892–902.

A. El-Kardocy, Y.A. Mostafa, N.G. Mohamed, M.N. Abo-Zeid, N.A. Hassan, H. F. Hetta, A.-B.-M. Abdel-Aal, CK2 inhibition, lipophilicity and anticancer activity of new N 1 versus N 2-substituted tetrabromobenzotriazole regioisomers, New J. Chem. 44 (30) (2020) 13007–13017.

A. Abdelfattah, A.E. Aboutaleb, A.-B. Abdel-Aal, A.A.H. Abdellatif, H.M. Tawfeek, S.I. Abdel-Rahman, Design and optimization of PEGylated silver nanoparticles for efficient delivery of doxorubicin to cancer cells, J. Drug Delivery Sci. Technol. 71 (2022) 103347.

T. Ahipa, A.V. Adhikari, 2-Methoxypyridine derivatives: synthesis, liquid crystalline and photo-physical properties, New J. Chem. 38 (10) (2014) 5018–5029.

This material may be protected under Copyright Act which governs the making of photocopies or reproductions of copyrighted materials.
You may use the digitized material for private study, scholarship, or research.

Back to previous page